Chemotherapy strategy for colorectal cancer under the outbreak of corona virus disease 2019
10.3760/cma.j.cn.441530-20200225-00089-1
- VernacularTitle:新型冠状病毒肺炎疫情下的结直肠癌患者化疗策略
- Author:
Yanhao LI
1
;
Lin SHEN
;
Jian LI
Author Information
1. 北京大学肿瘤医院暨北京市肿瘤防治研究所 恶性肿瘤发病机制及转化研究教育部重点实验室 消化肿瘤内科 100142
- Keywords:
Corona virus disease 2019;
Colorectal neoplasms;
Chemotherapy
- From:
Chinese Journal of Gastrointestinal Surgery
2020;23(3):217-219
- CountryChina
- Language:Chinese
-
Abstract:
The outbreak of corona virus disease 2019 (COVID-19) makes the medical treatment of colorectal cancers difficult. Cancer patients are more susceptible to infection and tumor history is defined as an important factor of poor prognosis, which challenges both doctors and patients. For metastatic colorectal cancer (CRC) patients, maintenance therapy is the optimal choice. The patients with tumor progression or poor biological behavior should receive or continue combination chemotherapy. Adjuvant chemotherapy should reduce the intensity of treatment and shorten the therapy time. Fever patients during chemotherapy need to receive differential diagnosis and screening according to national standards. Patients with stable diseases and good general conditions may delay imaging examination. Clinicians should make individual clinical decisions based on the specifics of each patient during epidemic situation.
